Fig. 4
From: CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
CD200 expression in AML with biallelic CEBPA mutation. Immunophenotype from one AML patient with biallelic CEBPA mutation (UPN: 102; c.68delC // P23fsX137) which is associated with P2 (fully positive), expressed 80.08% CD200-positive cells. Red: Leukemic cells expressing CD200